Orion Therapeutics, Inc.
Dr. Michael McCaman is an author and experienced business leader in the field of biotechnology with 35 years of experience in the pharmaceutical development of biological therapeutics including proteins, antibodies, cell therapies, and viral/non-viral delivery systems. Dr. McCaman’s specialties range from formulation and process development to CMC and the commercialization of drug products. He is widely published with more than 25 peer-reviewed journal articles and several book chapters and reviews in pharmaceutical drug development.
This person is not in any teams
This person is not in any offices
Orion Therapeutics, Inc.
Orion Therapeutics is a biotechnology company that develops early-stage DNA/RNA therapeutics and vaccines. Its patented lipid nanoparticles are comprised of 100% natural components and incorporate dually functional lipopeptides during the nanoformulation process for efficient loading and enhanced target cell delivery.